ImmuCell Corporation (ICCC) NASDAQ
9.79
+0.12(+1.24%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 55.51M |
| Enterprise Value | 64.9M |
| P/E Ratio | -162.38 |
| PEG Ratio | 0.32 |
| Price/Sales Ratio | 2.96 |
| Price/Book Ratio | 3.04 |
| Enterprise/Revenue | 3.16 |
| Enterprise/EBITDA | 41.07 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.02 |
| Operating Margin | 0.08 |
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.02 |
Income Statement
| Revenue | 27.64M |
| Revenue/Share | 3.31 |
| Gross Profit | 11.45M |
| EBITDA | 2.14M |
| Net Income | -1.04M |
| Diluted EPS | -0.12 |
Balance Sheet
| Total Cash | 6.81M |
| Total Cash/Share | 0.75 |
| Total Debt | 12.78M |
| Total Debt/Equity | 0.44 |
| Current Ratio | 4.82 |
| Book Value Per Share | 3.22 |
Price History
| 52-Week Change | 44.4 |
| 52-Week High | 10.75 |
| 52-Week Low | 4.52 |
| Moving Average 50 Days | 8.16 |
| Moving Average 200 Days | 6.63 |
Statistics
| Average Volume | 25,660 |
| Shares Outstanding | 9.05M |
| % Held by Institutions | 15.17 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
| Last Split Date | July 25, 1990 |
